Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.39 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.39 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.39 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.39 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4F8 | P98187 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21625025 | 0.80 | TP53 (0.41) | CYP1A2CYP3A4CYP2D6CYP2C19GAA | |
| SCHEMBL8765389 | 0.78 | LMNA (0.45) | CYP3A4MEN1GAAKMT2AALDH1A1 | |
| SCHEMBL30307078 | 0.77 | CYP1A2 (0.60) | CYP1A2CYP2A6NQO2CYP3A4CYP1A1 | |
| SCHEMBL5746518 | 0.77 | CYP1A2 (0.60) | CYP1A2CYP2A6NQO2CYP3A4CYP1A1 | |
| SCHEMBL23722664 | 0.76 | LTA4H (0.41) | CYP3A4MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL5031545 | 0.74 | CYP1A2 (0.39) | CYP1A2CYP2A6CYP3A4CYP1A1CYP1B1 | |
| SCHEMBL2514862 | 0.73 | LMNA (0.33) | KDM4ECA2 | |
| SCHEMBL9746092 | 0.72 | CYP1A2 (0.48) | CYP1A2CYP2A6NQO2CYP3A4CYP1A1 | |
| Anthracene SCHEMBL28605065 | 0.72 | ALDH1A1 (0.48) | CYP1A2CYP2A6NQO2CYP3A4CYP1A1 | |
| SCHEMBL25122114 | 0.72 | CYP1A2 (0.36) | CYP1A2CYP2A6NQO2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20250163200-A1 | DIPHENYL(METH)ACRYLAMIDE-CONTAINING THERMOSETTING RESIN COMPOSITION AND CURED PRODUCT THEREFROM | NIPPON SODA CO., LTD. (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4501994-A1 | DIPHENYL(METH)ACRYLAMIDE-CONTAINING THERMOSETTING RESIN COMPOSITION AND CURED PRODUCT THEREFROM | Nippon Soda Co., Ltd. (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20240409674-A1 | NOVEL POLYMER, RESIN COMPOSITION INCLUDING SAME, AND MOLDED BODY THEREOF | NIPPON SODA CO., LTD. (JP) | 2024-12-12 | — | — | US | disclosed |
| CN-118871485-A | Thermosetting resin composition containing diphenyl (methyl) acrylamide and its cured product | 日本曹达株式会社 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024219272-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | 日本化薬株式会社 | 2024-10-24 | — | — | WO | disclosed |
| US-20240309138-A1 | NOVEL (METH)ACRYLAMIDE POLYMER, RESIN COMPOSITION CONTAINING SAME, AND MOLDED BODY THEREOF | NIPPON SODA CO., LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| US-12024590-B2 | Resin composition, prepreg, film with resin, metal foil with resin, metal-clad laminate, and wiring board | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| EP-4372015-A1 | NOVEL POLYMER, RESIN COMPOSITION INCLUDING SAME, AND MOLDED BODY THEREOF | Nippon Soda Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| EP-4372019-A1 | NOVEL (METH)ACRYLAMIDE POLYMER, RESIN COMPOSITION CONTAINING SAME, AND MOLDED BODY THEREOF | Nippon Soda Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-20140178820-A1 | RESIST COMPOSITION, PATTERNING PROCESS AND POLYMER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-06-26 | — | — | US | disclosed |
| US-20140178818-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-06-26 | — | — | US | disclosed |
| US-20140178818-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-06-26 | — | — | US | disclosed |
| US-20140065544-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-03-06 | — | — | US | disclosed |
| US-5847006-A | Therapeutic guanidines | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0746316-A4 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE INC (US) | 1997-12-10 | — | — | EP | disclosed |
| EP-0505972-B1 | Process for producing styrenic copolymer | IDEMITSU KOSAN CO (JP) | 1997-06-11 | — | — | EP | disclosed |
| EP-0746316-A1 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1996-12-11 | — | — | EP | disclosed |
| WO-1995014467-A1 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1995-06-01 | — | — | WO | disclosed |
| EP-0505972-A2 | Process for producing styrenic copolymer | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | PSMA1, PSMB10, RAD51 | CYP1A2 2570/4885CYP2A6 1938/4885NQO2 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.